Aditxt, Inc. Finite-Lived Intangible Assets, Accumulated Amortization
Aditxt, Inc. (ADTX) had Finite-Lived Intangible Assets, Accumulated Amortization of -$329.06 thousand as of 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization · last filed 2026-05-20
- 2026-03-31: Finite-Lived Intangible Assets, Accumulated Amortization -$329.06K.
- 2025-12-31: Finite-Lived Intangible Assets, Accumulated Amortization -$328.22K.
- 2025-09-30: Finite-Lived Intangible Assets, Accumulated Amortization -$327.39K.
- 2025-06-30: Finite-Lived Intangible Assets, Accumulated Amortization -$326.56K.
| Period end | Finite-Lived Intangible Assets, Accumulated Amortization | Finite-Lived Intangible Assets, Accumulated Amortization as first filed |
|---|---|---|
| 2026-03-31 | -$329.06K 10-Q · filed 2026-05-20 | |
| 2025-12-31 | -$328.22K 10-Q · filed 2026-05-20 | |
| 2025-09-30 | -$327.39K 10-Q · filed 2025-11-18 | |
| 2025-06-30 | -$326.56K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | -$325.72K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | -$324.89K 10-K · filed 2026-03-31 | |
| 2024-09-30 | -$324.06K 10-Q · filed 2024-11-18 | |
| 2024-06-30 | -$323.22K 10-Q · filed 2024-08-19 | |
| 2024-03-31 | -$322.39K 10-Q · filed 2024-05-20 | |
| 2023-12-31 | -$321.56K 10-K · filed 2025-03-31 | $321.56K 10-K · filed 2024-04-16 |
| 2023-09-30 | $294.25K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $267.50K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $240.75K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $214.00K 10-K · filed 2024-04-16 | |
| 2022-09-30 | $187.25K 10-Q · filed 2022-11-14 | |
| 2021-12-31 | $107.00K 10-Q · filed 2022-11-14 | |
| 2021-09-30 | -$80.03K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$53.06K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | -$26.38K 10-Q · filed 2021-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |